Outcome Research of a European Registry Platform on Real-world Treatment Data of Patients with Advanced NMSC

Recruiting now

Conditions studied: Basal Cell Carcinoma, Cutaneous Squamous Cell Carcinoma

In brief

This current registry study will analyze real-world data to address questions about disease characteristics and treatment patterns in NMSC patients based on the European NMSC-Registry. The overall objective is to describe characteristics, management and treatment outcomes for patients presenting with advanced NMSC (cSCC/BCC) or HR-cSCC in routine clinical practice, independent of treatments used across different European regions.

Key facts

Study ID

NCT05741073

Run by

EuMelaReg gGmbH

People needed

1300

Starts

2023-06-30

Expected to finish

2027-12-01

Last updated by the study team

2025-03-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged ≥18 years at index date
• Patients documented in the European NMSC-registry fulfilling EMR quality standard
• Patients with resected HR-cSCC (Cohort 1) receiving only postoperative radiotherapy or watchful waiting OR Patients with advanced cSCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 2) OR Patients with advanced BCC who are not candidates for curative surgery/radiation in routine clinical practice (Cohort 3)

You may not qualify if…

• Patients receiving treatment within a clinical trial.

Where it is running

• UZ (Universitair Ziekenhuis) Brüssel — Brussels, Belgium (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.